Delivery Order SPE2DB22D6029-SPE2DB24FU0YE
- Not listed
- This contract award, with ID SPE2DB20D2014|SPE2DB25FA95G, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of clonidine hydrochloride extended-release 0.1 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,519.08 and a period of performance ending on February 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,947.80 Delivery Order is for the supply of Clonidine Hydrochloride Extended-Release 0.1 mg tablets in 60-count bottles. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,640.85, is for the delivery of clonidine hydrochloride extended-release 0.1 mg tablets. The contract is a firm fixed-price delivery order with a performance period ending on December 15, 2023. This contract award is not designated as a set-aside and appears to be part of a larger Indefinite...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,127.80, is for the delivery of Clonidine Hydrochloride Extended Release 0.1 milligram tablets in 60-count packages. The contract is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, identified as SPE2DB22D2206|SPE2DB25FEB55, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Clonidine HCL ER 0.1 mg tablets in 60-count packages, with a ceiling value of $1,606.51 and a completion date of November 5, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $2,489.45. The contract is for the delivery of clonidine hydrochloride extended-release 0.1 mg tablets in 60-count packages. The contract has an ultimate completion date of March 3, 2025 and was awarded on February 28, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,900.30 firm fixed-price delivery order is for the supply of 4562815802 - Clonidine HCL ER 0.1 mg Tablets in 60-count packages. The contract has an ultimate completion date of November 15, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,912.42, is for the delivery of Clonidine HCL ER 0.1 mg tablets in 60-count packages. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical division. This IDC serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,085.27 firm-fixed-price delivery order is for the supply of 60-count clonidine hydrochloride extended-release 0.1 mg tablets. The contract has an ultimate completion date of January 4, 2024 and was awarded on January 3, 2024. No set-aside designation was used for this procurement. Amerisourcebergen holds a...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Clonidine HCl ER 0.17 mg tablets. The contract has a ceiling value of $4,590.39 and a completion date of June 21, 2024. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB24FU0YEDelivery Order
This federal contract award, with ID SPE2DB22D6029 and SPE2DB24FU0YE, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of clonidine hydrochloride extended-release 0.1 mg tablets in 60-count packages, with a ceiling value of $1,346.72 and a completion date of May 14, 2024. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 5/13/24 |